Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression
Tóm tắt
The objective of this study is to explore the associations between the patient-reported Edinburgh Postnatal Depression Scale (EPDS) and Patient Health Questionnaire (PHQ)-9 and clinician-reported 17-item Hamilton Depression Rating Scale (HAMD-17) in order to facilitate clinical decision-making. An integrated efficacy dataset of three randomized placebo-controlled trials (NCT02614547, NCT02942004, and NCT02942017) evaluating brexanolone injection, a neuroactive steroid chemically identical to allopregnanolone, in women with postpartum depression was used for this post hoc analysis. Data were pooled across treatment arms. Associations were assessed at day 30 (end-of-trial follow-up). Pearson correlation assessed the relationship between EPDS and PHQ-9 item and total scores and HAMD-17 total score. Cohen’s kappa assessed agreement of EPDS remission (score < 10) and PHQ-9 remission (score < 5) with HAMD-17 remission (score ≤ 7). Ordinary least squares (OLS) regression models were used to develop equations estimating HAMD-17 total scores from EPDS and PHQ-9 scores, respectively. The total scores showed large correlations (HAMD-17/EPDS: r = 0.71, p < 0.001; HAMD-17/PHQ-9: r = 0.75, p < 0.001). Individual EPDS and PHQ-9 items significantly correlated (r= 0.35 to 0.67, all p < 0.001) with HAMD-17 total score. EPDS had 79% sensitivity and 67% specificity to detect HAMD-17 remission; corresponding estimates for PHQ-9 were 76% and 78%. OLS models yielded the following equations: HAMD-17 total = 2.66 + (EPDS total × 0.87) and HAMD-17 total = 3.99 + (PHQ-9 total × 0.97). There were large and statistically significant associations between patient-reported outcomes (EPDS, PHQ-9) and clinician-reported outcomes (HAMD-17) as clinical improvements were associated with patient-reported symptom improvement. These results provide tools to help translate clinical trial data to clinical practice, thus aiding shared decision-making for this critical population.
Tài liệu tham khảo
ACOG Committee Opinion No. 757 (2018) Obstet Gynecol 132:1314–1316. https://doi.org/10.1097/AOG.0000000000002928
Appleby L, Warner R, Whitton A, Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 314:932–936. https://doi.org/10.1136/bmj.314.7085.932
Bagby RM, Ryder AG, Schuller DR, Marshall MB (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161:2163–2177. https://doi.org/10.1176/appi.ajp.161.12.2163
Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77–100. https://doi.org/10.1016/0272-7358(88)90050-5
Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR (2004) Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 103:698–709. https://doi.org/10.1097/01.AOG.0000116689.75396.5f
Callaghan WM, Kuklina EV, Berg CJ (2010) Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 202(353):e351–e356. https://doi.org/10.1016/j.ajog.2010.01.011
Centers for Disease Control and Prevention (2018) Diabetes during pregnancy. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/diabetes-during-pregnancy.htm. Accessed March 31 2020
Centers for Disease Control and Prevention (2019) Data on selected pregnancy complications in the United States. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregnancy-complications-data.htm. Accessed March 31 2020
Clayton AH, Tourian KA, Focht K, Hwang E, Cheng RF, Thase ME (2015) Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial. J Clin Psychiatry 76:562–569. https://doi.org/10.4088/JCP.13m08978
Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782–786. https://doi.org/10.1192/bjp.150.6.782
Cox EQ, Sowa NA, Meltzer-Brody SE, Gaynes BN (2016) The perinatal depression treatment cascade: baby steps toward improving outcomes. J Clin Psychiatry 77:1189–1200. https://doi.org/10.4088/JCP.15r10174
De Sisto CL, Kim SY, Sharma AJ (2014) Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis 11. https://doi.org/10.5888/pcd11.130415
First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). American Psychiatric Press, Washington, DC
Flynn HA, Sexton M, Ratliff S, Porter K, Zivin K (2011) Comparative performance of the Edinburgh Postnatal Depression Scale and the Patient Health Questionnaire-9 in pregnant and postpartum women seeking psychiatric services. Psychiatry Res 187:130–134. https://doi.org/10.1016/j.psychres.2010.10.022
Gjerdingen D, Crow S, McGovern P, Miner M, Center B (2009) Postpartum depression screening at well-child visits: validity of a 2-question screen and the PHQ-9. Ann Fam Med 7:63–70. https://doi.org/10.1370/afm.933
Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I (2017) Economic and health predictors of national postpartum depression prevalence: a systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries. Front Psychiatry 8:248. https://doi.org/10.3389/fpsyt.2017.00248
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hantsoo L, Ward-O'Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN (2014) A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology 231:939–948. https://doi.org/10.1007/s00213-013-3316-1 Epub 2013 Oct 31
Harris B, Huckle P, Thomas R, Johns S, Fung H (1989) The use of rating scales to identify post-natal depression. Br J Psychiatry 154:813–817. https://doi.org/10.1192/bjp.154.6.813
Hinkle DE, Wiersma W, Jurs SG (2003) Applied statistics for the behavioral sciences, 5th edn. Houghton Mifflin, Boston
Ji S, Long Q, Jeffrey Newport D, Na H, Knight B, Zach EB, Morris NJ, Kutner M, Stowe ZN (2011) Validity of depression rating scales during pregnancy and the postpartum period: impact of trimester and parity. J Psychiatr Res 45:213–219. https://doi.org/10.1016/j.jpsychires.2010.05.017
Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S (2017) Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 390:480–489. https://doi.org/10.1016/s0140-6736(17)31264-3 Epub 2017 Jun 12
Khan A, Khan SR, Shankles EB, Polissar NL (2002) Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol 17:281–285
Kim DR, Epperson CN, Weiss AR, Wisner KL (2014) Pharmacotherapy of postpartum depression: an update. Expert Opin Pharmacother 15:1223–1234. https://doi.org/10.1517/14656566.2014.911842 Epub 2014 Apr 29
Ko JY, Rockhill KM, Tong VT, Morrow B, Farr SL (2017) Trends in postpartum depressive symptoms - 27 states, 2004, 2008, and 2012. MMWR Morb Mortal Wkly Rep 66:153–158. https://doi.org/10.15585/mmwr.mm6606a1
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174. https://doi.org/10.2307/2529310
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK (2019) Births: final data for 2018. Natl Vital Stat Rep Volume 68, Number 13. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_13-508.pdf. Accessed March 31 2020
McCabe-Beane JE, Segre LS, Perkhounkova Y, Stuart S, O’Hara MW (2016) The identification of severity ranges for the Edinburgh Postnatal Depression Scale. Journal of Reproductive and Infant Psychology 34:293–303. https://doi.org/10.1080/02646838.2016.1141346
Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S (2018a) Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet 392:1058–1070. https://doi.org/10.1016/s0140-6736(18)31551-4 Epub 2018 Aug 31
Meltzer-Brody S, Howard LM, Bergink V, Vigod S, Jones I, Munk-Olsen T, Honikman S, Milgrom J (2018b) Postpartum psychiatric disorders. Nat Rev Dis Primers 4:18022. https://doi.org/10.1038/nrdp.2018.22
Moore Simas TA, Huang M-Y, Patton C, Reinhart M, Chawla AJ, Clemson C, Eldar-Lissai A (2019) The humanistic burden of postpartum depression: a systematic literature review. Curr Med Res Opin 35:383–393. https://doi.org/10.1080/03007995.2018.1552039
Murray L, Carothers AD (1990) The validation of the Edinburgh Post-natal Depression Scale on a community sample. Br J Psychiatry 157:288–290. https://doi.org/10.1192/bjp.157.2.288
Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohen LS (2005) Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 8:445–449. https://doi.org/10.1017/S1461145705005079
O'Connor E, Rossom RC, Henninger M, Groom HC, Burda BU (2016) Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA 315:388–406. https://doi.org/10.1001/jama.2015.18948
Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M (2012) L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169:1267–1274. https://doi.org/10.1176/appi.ajp.2012.11071114
Price D (2005) Sharing clinical decisions by discussing evidence with patients. Perm J 9:70–73. https://doi.org/10.7812/tpp/05-006
Roberts JM et al (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122:1122–1131. https://doi.org/10.1097/01.AOG.0000437382.03963.88
Salkind N (2010) Restriction of range. In: Encyclopedia of research design. SAGE Publications, Inc., Thousand Oaks, California. doi:https://doi.org/10.4135/9781412961288.n388, Restriction of Range
Sharp DJ et al (2010) A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess 14(iii-iv, ix-xi):1–153. https://doi.org/10.3310/hta14430
Sidebottom AC, Harrison PA, Godecker A, Kim H (2012) Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening. Arch Womens Ment Health 15:367–374. https://doi.org/10.1007/s00737-012-0295-x
Sit DK, Wisner KL (2009) Identification of postpartum depression. Clin Obstet Gynecol 52:456–468. https://doi.org/10.1097/GRF.0b013e3181b5a57c
Smith EK, Gopalan P, Glance JB, Azzam PN (2016) Postpartum depression screening: a review for psychiatrists. Harv Rev Psychiatry 24:173–187. https://doi.org/10.1097/HRP.0000000000000103
Spinelli MG, Endicott J, Leon AC, Goetz RR, Kalish RB, Brustman LE, Carmona YR, Meyreles Q, Vega M, Schulick JL (2013) A controlled clinical treatment trial of interpersonal psychotherapy for depressed pregnant women at 3 New York City sites. J Clin Psychiatry 74:393–399. https://doi.org/10.4088/JCP.12m07909
Vismara L, Rollè L, Agostini F, Sechi C, Fenaroli V, Molgora S, Neri E, Prino LE, Odorisio F, Trovato A, Polizzi C, Brustia P, Lucarelli L, Monti F, Saita E, Tambelli R (2016) Perinatal parenting stress, anxiety, and depression outcomes in first-time mothers and fathers: a 3- to 6-months postpartum follow-up study. Front Psychol 7:938. https://doi.org/10.3389/fpsyg.2016.00938
Zhong Q, Gelaye B, Rondon M, E. Sánchez S, J. García P, Sánchez E, V. Barrios Y, E. Simon G, C. Henderson D, May Cripe S, A. Williams M (2014) Comparative performance of Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale for screening antepartum depression. J Affect Disord 162:1–7. https://doi.org/10.1016/j.jad.2014.03.028